Medical nutrition therapy provided by RDNs benefits patients with chronic kidney disease

According to a new review, approximately 30 million Americans – about 15 percent of adults – have chronic kidney disease, a number that is expected to increase in the next 20 years due to rising obesity rates and longer lifespans, but the majority of chronic kidney disease patients aren't receiving potentially lifesaving treatment.

"Medical Nutrition Therapy for Patients with Non-Dialysis-Dependent Chronic Kidney Disease: Barriers and Solutions" was compiled by a multidisciplinary team that included registered dietitian nutritionists, patient advocates and physicians from the Academy of Nutrition and Dietetics, the National Kidney Foundation, Loyola University Chicago and the University of New Mexico. It will be published in the October issue of the Journal of the Academy of Nutrition and Dietetics and is available online.

Nearly 90 percent of patients with chronic kidney disease never meet with a registered dietitian nutritionist, according to the review. Some physicians may lack confidence in MNT's effectiveness; others may be unaware that MNT is covered by Medicare Part B for patients who are not on dialysis. Patients may be reluctant to invest the time and money in the therapy if it is not covered by their insurance.

"Most patients don't understand how big a role their diet plays in the management of their kidney disease," said co-author Marsha Schofield, a registered dietitian and the Academy's senior director of governance. "Medical nutrition therapy helps patients with chronic kidney disease improve their blood sugar and blood pressure, which will slow the progression of the disease and even delay or prevent them from needing to have dialysis or a transplant."

"The Academy and the National Kidney Foundation have a long history of collaborating to advance the science and clinical practice around kidney disease," Schofield said. "Both of our organizations recommend MNT for all people with CKD."

The authors say more research is needed to study and remove barriers to obtaining MNT.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Phase 3 trial assesses clazakizumab in kidney transplant recipients with caAMR